How can we increase the number of patients being treated?
Can more stroke patients reach functional independence? 
Find out how clinical and economic data can help you to optimize stroke care.

what medtronic

your need a solution designed for your case

find out how we can help
hcp image
icon 1

Comprehensive and flexible health economics solutions suitable for multiple stakeholders

icon 2

Patient clinical benefit and cost implication estimates for hospitals and the health care system

icon 3

Training and medical education programs

icon 4

A team of experts,
ready to talk to you! 

generating evidence

Medtronic has supported health economics studies* in 14 countries globally since 20151-16.


Argentina, Australia, Austria, Chile, Colombia, Italy, Poland, Portugal, Russia, Saudi Arabia, Singapore, Spain, United Kingdom, United States of America

map image

16 health economics studies across 14 countries since 2015

100% cost-effectiveness analysis concluded that mechanical thrombectomy is cost-effective or cost saving

*over 60%

of the studies have been published in peer reviewed journals or considered for reimbursement by HTA/Reimbursement authorities (Australia, Poland and Russia). 

request a study


Partner with Medtronic and focus on what matters:
The urgent care you need to provide to give patients a better chance to recover from stroke.



*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center


de Andrés-Nogales, Fernando, et al. "Cost-effectiveness of mechanical thrombectomy using stent retriever after intravenous tissue plasminogen activator compared with intravenous tissue plasminogen activator alone in the treatment of acute ischaemic stroke due to large vessel occlusion in Spain." European Stroke Journal 2.3 (2017): 272-284.


Ruggeri, Matteo, et al. "Cost-effectiveness analysis of mechanical thrombectomy with stent retriever in the treatment of acute ischemic stroke in Italy." Journal of Medical Economics 21.9 (2018): 902-911.


 Lobotesis, Kyriakos, et al. "Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK." Journal of Medical Economics 19.8 (2016): 785-794.


Ni, Weiyi, et al. "Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective." BMJ open 10.9 (2020): e036517.


Lenz-Alcayaga, Rony, et al. "Cost-utility analysis: Mechanical thrombectomy plus thrombolysis in ischemic stroke due to large vessel occlusion in the public sector in Chile." Medwave 21.3 (2021): e8152-e8152.


Arora, Nimita, et al. "Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective." Journal of medical economics 21.8 (2018): 799-809.


Al-Senani, Fahmi, et al. "A national economic and clinical model for ischemic stroke care development in Saudi Arabia: A call for change." International Journal of Stroke 14.8 (2019): 835-842.


Dombrovsky V. S., Ivakhnenko O. I., Avksentyeva M. V., Omelyanovskiy V. V., Musina N. Z. Efficacy and Efficiency of Mechanical Thromboextraction in Combination with Thrombolytic Therapy or as an Independent Method of Intravascular Treatment in Patients with Ischemic Stroke. Medical technologies. Evaluation and selection. 2018; 2 (32): 48–59. 


Shireman, Theresa I., et al. "Cost-effectiveness of Solitaire stent retriever thrombectomy for acute ischemic stroke: results from the SWIFT-PRIME trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)." Stroke 48.2 (2017): 379-387.


Genovez, V., et al. "PCV37 Cost-Effectiveness Analysis of IV-TPA Followed By Mechanical Thrombectomy with Stent-Retriever versus IV-TPA alone in the treatment of Acute Ischemic Stroke due to Large Vessel Occlusion in Portugal." Value in Health 23 (2020): S493.


Pabon, B., et al. "P-018 Cost-effectiveness of endovascular stroke therapy. analysis from a Colombian healthcare perspective." (2019): A34-A35.


Pochopien M. et al. Cost-effectiveness analysis of mechanical thrombectomy in acute phase of ischemic stroke (AIS). Value in Health Volume 2017; 20, Issue 9, October–November 2017, Page A578.


Alcayaga, R. Lenz, et al. “PMD22: Budget Impact Analysis of the incorporation of mechanical thrombectomy with stent retrievers after thrombolysis in ischemic stroke with large vessel occlusion in the Chilean public sector.” Value in Health (2020), ISSN: 1098-3015, Vol: 23, Page: S192. 


Lylyk, P., et al. "PND28 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Obras Sociales and Empresas De Medicina Prepaga in Argentina." Value in Health 24 (2021): S163-S164.


Lylyk, P., et al. "PND24 Cost-Utility of Mechanical Thrombectomy after Thrombolysis in Ischemic-Stroke due to Large Vessel Occlusion in Programa de Atencion medica Integral Pami in Argentina." Value in Health 24 (2021): S163.


Austria: Data on file.